Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection
Elizabeth Hamlyn(National Health Service), Jonathan Weber(Imperial College London), Kholoud Porter(The Royal Free Hospital), Sarah Fidler(NIHR Imperial Biomedical Research Centre), Giuseppe Tambussi(San Raffaele University of Rome), Jason F. Okulicz(Gilead Sciences (United States)), Court Pedersen(Office of Infectious Diseases), Mauro Schechter(Universidade Federal do Rio de Janeiro), David A. Cooper(Illinois Institute of Technology), Abdel Babiker(MRC Clinical Trials Unit at UCL), Myra O. McClure(Imperial College London), Fiona M Ewings(Medical Research Council)
Cited by 71
Related Papers
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Treatment for Adult HIV Infection in 2002
|JAMA|2002|713
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358